Sovereign Metals announced that incorporating rare earth recovery into its Kasiya project in Malawi could add an incremental pre-tax net present value (NPV) of $722 million, requiring about $29 million in capital to reach production. A scoping study estimates a 151% pre-tax internal rate of return and a payback period of roughly 1.5 years. The project could produce around 2,626 tonnes of rare earth concentrate annually, including valuable elements like neodymium-praseodymium, dysprosium, terbium, and yttrium. Next steps include variability testing, product qualification, marketing efforts, and potential offtake discussions ahead of a targeted pre-feasibility study in 2027. The study is preliminary and does not yet confirm Ore Reserves or economic viability.
Fortrea Holdings and Omico have formed a partnership to enhance precision oncology research in Australia by linking cancer patients to biomarker-matched clinical trials. This collaboration combines Fortrea's oncology trial expertise with Omico's Prec...
Fortrea Holdings Inc and Omico have formed a partnership to accelerate precision oncology research in Australia by connecting cancer patients to biomarker-driven clinical trials. The collaboration combines Fortrea's expertise in oncology clinical tri...
Fortrea Holdings and Omico have formed a partnership to accelerate precision oncology research in Australia by combining Fortrea's clinical trial expertise with Omico's Precision Oncology Screening Platform (PrOSPeCT). This collaboration aims to impr...
Fortrea Holdings Inc and Omico have formed a partnership to enhance precision oncology research in Australia by matching cancer patients with biomarker-driven clinical trials. This collaboration combines Fortrea's expertise in oncology clinical trial...
Fortrea Holdings and Omico have formed a partnership to accelerate precision oncology research by improving biomarker-based clinical trial planning and patient recruitment in Australia. The collaboration leverages Fortrea's clinical trial expertise a...
